Folgen
Fatemeh Mosaffa
Fatemeh Mosaffa
Professor of Pharmaceutical Biotechnology, Mashhad University of Medical Sciences
Bestätigte E-Mail-Adresse bei mums.ac.ir
Titel
Zitiert von
Zitiert von
Jahr
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
L Arabi, A Badiee, F Mosaffa, MR Jaafari
Journal of controlled release 220, 275-286, 2015
1772015
Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species
L Hosseinzadeh, J Behravan, F Mosaffa, G Bahrami, A Bahrami, G Karimi
Food and Chemical Toxicology 49 (5), 1102-1109, 2011
1422011
Single-walled carbon nanotubes functionalized with aptamer and piperazine–polyethylenimine derivative for targeted siRNA delivery into breast cancer cells
M Mohammadi, Z Salmasi, M Hashemi, F Mosaffa, K Abnous, ...
International journal of pharmaceutics 485 (1-2), 50-60, 2015
1092015
Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors
N Shobeiri, M Rashedi, F Mosaffa, A Zarghi, M Ghandadi, A Ghasemi, ...
European journal of medicinal chemistry 114, 14-23, 2016
1022016
Protective effects of aqueous and ethanolic extracts of Portulaca oleracea L. aerial parts on H2O2-induced DNA damage in lymphocytes by comet assay
J Behravan, F Mosafa, N Soudmand, E Taghiabadi, BM Razavi, G Karimi
Journal of Acupuncture and Meridian Studies 4 (3), 193-197, 2011
892011
Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells
S Taghavi, A HashemNia, F Mosaffa, S Askarian, K Abnous, M Ramezani
Colloids and Surfaces B: Biointerfaces 140, 28-39, 2016
802016
Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer
SM Taghdisi, K Abnous, F Mosaffa, J Behravan
Journal of drug targeting 18 (4), 277-281, 2010
802010
Synthesis, structure-activity relationship and molecular docking studies of novel quinoline-chalcone hybrids as potential anticancer agents and tubulin inhibitors
S Mirzaei, F Hadizadeh, F Eisvand, F Mosaffa, R Ghodsi
Journal of Molecular Structure 1202, 127310, 2020
772020
Auraptene from Ferula szowitsiana protects human peripheral lymphocytes against oxidative stress
F Soltani, F Mosaffa, M Iranshahi, G Karimi, M Malekaneh, F Haghighi, ...
Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2010
672010
Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins
J Kasaian, F Mosaffa, J Behravan, M Masullo, S Piacente, M Ghandadi, ...
Fitoterapia 103, 149-154, 2015
602015
Protective effect of silymarin against acrolein-induced cardiotoxicity in mice
E Taghiabadi, M Imenshahidi, K Abnous, F Mosafa, M Sankian, B Memar, ...
Evidence-Based Complementary and Alternative Medicine 2012, 2012
602012
Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX
F Mosaffa, H Lage, JT Afshari, J Behravan
Inflammation research 58, 669-676, 2009
602009
Evaluation of antigenotoxicity effects of umbelliprenin on human peripheral lymphocytes exposed to oxidative stress
F Soltani, F Mosaffa, M Iranshahi, G Karimi, M Malekaneh, F Haghighi, ...
Cell biology and toxicology 25, 291-296, 2009
602009
Crosstalk in cancer resistance and metastasis
S Norouzi, MG Valokala, F Mosaffa, MR Zirak, P Zamani, J Behravan
Critical Reviews in Oncology/Hematology 132, 145-153, 2018
572018
Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells
F Mosaffa, F Kalalinia, H Lage, JT Afshari, J Behravan
Molecular and cellular biochemistry 363, 385-393, 2012
562012
Design, synthesis and biological evaluation of novel 5, 6, 7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors
S Mirzaei, F Eisvand, F Hadizadeh, F Mosaffa, A Ghasemi, R Ghodsi
Bioorganic Chemistry 98, 103711, 2020
552020
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
A Razazan, J Behravan, A Arab, N Barati, L Arabi, Z Gholizadeh, ...
PloS one 12 (10), e0185099, 2017
552017
Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines
MY Hanafi-Bojd, M Iranshahi, F Mosaffa, SO Tehrani, F Kalalinia, ...
Planta medica 77 (14), 1590-1593, 2011
532011
A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice
A Arab, J Behravan, A Razazan, Z Gholizadeh, AR Nikpoor, N Barati, ...
Journal of drug targeting 26 (4), 365-372, 2018
462018
Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors
SR Oskuei, S Mirzaei, MR Jafari-Nik, F Hadizadeh, F Eisvand, F Mosaffa, ...
Bioorganic Chemistry 112, 104904, 2021
442021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20